Rothschild & Co Asset Management US’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-224,946	Closed	-$4.52M	–	274
2020 Q4	$4.52M	Sell	224,946 -18,963	-8%	-$369K	0.06%	232
2020 Q3	$4.57M	Sell	243,909 -41,436	-15%	-$834K	0.08%	240
2020 Q2	$6.41M	Buy	285,345 +1,017	+0.4%	+$18.6K	0.09%	250
2020 Q1	$4.22M	Sell	284,328 -49,461	-15%	-$861K	0.07%	259
2019 Q4	$6.44M	Sell	333,789 -13,518	-4%	-$259K	0.07%	275
2019 Q3	$6.89M	Sell	347,307 -216	-0.1%	-$4.5K	0.07%	271
2019 Q2	$7.34M	Buy	347,523 +33,957	+11%	+$710K	0.08%	273
2019 Q1	$6.41M	Sell	313,566 -22,364	-7%	-$501K	0.07%	280
2018 Q4	$6.68M	Buy	335,930 +13,757	+4%	+$271K	0.08%	281
2018 Q3	$6.2M	Sell	322,173 -6,668	-2%	-$119K	0.06%	294
2018 Q2	$5.02M	Buy	328,841 +13,157	+4%	+$230K	0.05%	301
2018 Q1	$5.92M	Sell	315,684 -10,653	-3%	-$200K	0.07%	282
2017 Q4	$6.28M	Sell	326,337 -27,716	-8%	-$518K	0.07%	274
2017 Q3	$6.33M	Sell	354,053 -6,527	-2%	-$107K	0.07%	269
2017 Q2	$6.44M	Sell	360,580 -263,974	-42%	-$4.19M	0.07%	273
2017 Q1	$9.06M	Buy	+624,554	New	+$9.82M	0.1%	252